Share Buyback

The industrial chemical supplier doubles down on its share repurchase program, seeing its units as a bargain and a key part of its capital strategy.

With a healthy balance sheet and record profits, CEMATRIX signals confidence in its undervalued stock by renewing its share repurchase program for another year.

Alpha and Omega Semiconductor's upcoming results will offer key insights into the health of the AI, EV, and data center markets amid a cyclical downturn.

A Canadian drone maker gains top military approval in Ukraine, leveraging its unique 'ITAR-flexible' status to meet surging global defense demand.

The luxury automaker completes one buyback tranche and immediately launches another, reinforcing its multi-billion euro capital return strategy.

The employee-owned Colorado bank increased its shareholder payout, reflecting robust financial health and strategic gains in a changing banking landscape.

Dow projects continuity with board re-elections and its 459th dividend, but a closer look reveals concerns over dividend health and auditor oversight.

UPM holds its dividend steady while new board appointments and major capital authorizations signal a clear focus on strategic growth and transformation.

Enterprise Products Partners raises its distribution and buys back shares, showcasing financial strength ahead of key industry and earnings forecasts.

China's EdTech giant TAL is set to report Q4 earnings. Investors are watching closely to see if its pivot to AI and smart devices is a winning strategy.

Now a standalone firm under private equity owner AURELIUS, Landis+Gyr EMEA is set to disrupt the utility market after a strategic divestment.

As Option Care Health preps its Q1 results, investors watch if it can seize market share from a retreating rival while navigating major biosimilar headwinds.

The retailer posts modest annual growth despite a tough Q4, as international gains and efficiency drives offset major headwinds in its Canadian operations.

ADP's latest dividend declaration highlights its financial strength and commitment to shareholders, cementing its status as a reliable income-generating stock.

The energy tech giant completes its EMEA business divestiture to AURELIUS, sharpening focus on the Americas and APAC while reshaping Europe's grid market.

With stellar trial data for its cholesterol drug obicetrapib, NewAmsterdam Pharma faces investors as it navigates a competitive market and awaits key results.

DPM Metals reports strong Q1 results, balancing the Vareš mine ramp-up, Ada Tepe's closure, and aggressive Serbian exploration, all while rewarding investors.

Amid global volatility, B2PRIME Group announced record 2025 profits, a 5x surge in volume, and eliminated all debt, setting a new bar for resilience.

Insiders at AMTD IDEA Group, including the controlling shareholder, commit to a two-year share lock-up, a bold move to signal long-term faith in the firm.

Webull terminated a massive equity agreement after using only a fraction, signaling a major strategic pivot driven by record profits and growth.